Thursday, May 29, 2008
Dr. Peter Anton will present a summary review of the data presented at M2008 on the first IND-supported rectal microbicide Phase 1 trial (using UC781). The talk will highlight explanations of the various mucosal assays currently in use, the design issues confronted and blinded results, now that the subject portion is complete. Data lockdown and unblinding is planned for 6/1/08. Dr. Anton will also briefly describe the study design of the upcoming rectal microbicide trial using tenofovir (gel vs. oral.)
UCLA hosts this call at the following times. (Dial-in info is coming soon.)
3pm – UTC
Join IRMA by subscribing to our listserv. Dial-in info will be distributed via our email list for members.
Click here for presentations from previous IRMA teleconferences.